首页> Blood> The antigenic landscape of multiple myeloma: mass spectrometry (re)defines targets for T-cell-based immunotherapy.

The antigenic landscape of multiple myeloma: mass spectrometry (re)defines targets for T-cell-based immunotherapy.

导出 OA

翻译打印收藏纠错

第一作者： Simon,Walz

第一单位： Department of Hematology and Oncology, Institute for Cell Biology, Department of Immunology, and.

作者： Simon,Walz ^[1] ; Juliane S,Stickel ^[2] ; Daniel Johannes,Kowalewski ^[3] ; Heiko,Schuster ^[3] ; Katja,Weisel ^[2] ; Linus,Backert ^[4] ; Stefan,Kahn ^[3] ; Annika,Nelde ^[3] ; Tatjana,Stroh ^[3] ; Martin,Handel ^[5] ; Oliver,Kohlbacher ^[6] ; Lothar,Kanz ^[2] ; Helmut Rainer,Salih ^[7] ; Hans-Georg,Rammensee ^[8] ; Stefan,Stevanović ^[8]

作者单位： Department of Hematology and Oncology, Institute for Cell Biology, Department of Immunology, and. ^[1] Department of Hematology and Oncology. ^[2] Institute for Cell Biology, Department of Immunology, and. ^[3] Institute for Cell Biology, Department of Immunology, and Applied Bioinformatics, Center for Bioinformatics and Department of Computer Science, University of Tübingen, Tübingen, Germany; ^[4] Department of Orthopedics, Hospital Group South-West, Calw, Germany; and. ^[5] Applied Bioinformatics, Center for Bioinformatics and Department of Computer Science, University of Tübingen, Tübingen, Germany; ^[6] Department of Hematology and Oncology, Clinical Cooperation Unit Translational Immunology and. ^[7] Institute for Cell Biology, Department of Immunology, and Cancer Immunotherapy Unit, German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ) Partner Site Tübingen, Tübingen, Germany. ^[8]